Theriva Biologics Inc [AMEX: TOVX] gained 4.65% on the last trading session, reaching $0.49 price per share at the time.
If compared to the average trading volume of 910.11K shares, TOVX reached a trading volume of 14569435 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Theriva Biologics Inc [TOVX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TOVX shares is $7.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TOVX stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
The Average True Range (ATR) for Theriva Biologics Inc is set at 0.08 The Price to Book ratio for the last quarter was 0.09, with the Price to Cash per share for the same quarter was set at 1.22.
Trading performance analysis for TOVX stock
Theriva Biologics Inc [TOVX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 7.38. With this latest performance, TOVX shares dropped by -65.10% in over the last four-week period, additionally sinking by -61.83% over the last 6 months – not to mention a drop of -92.99% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TOVX stock in for the last two-week period is set at 30.21, with the RSI for the last a single of trading hit 32.46, and the three-weeks RSI is set at 31.77 for Theriva Biologics Inc [TOVX]. The present Moving Average for the last 50 days of trading for this stock 0.9970, while it was recorded at 0.4531 for the last single week of trading, and 1.6966 for the last 200 days.
Theriva Biologics Inc [TOVX]: A deeper dive into fundamental analysis
Theriva Biologics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.53 and a Current Ratio set at 1.53.
Theriva Biologics Inc [TOVX]: An earnings per share (EPS) analysis
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TOVX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Theriva Biologics Inc go to 36.86%.
An analysis of Institutional ownership at Theriva Biologics Inc [TOVX]
There are presently around $7.47%, or 7.48%% of TOVX stock, in the hands of institutional investors. The top three institutional holders of TOVX stocks are: MSD PARTNERS, L.P. with ownership of 0.6 million shares, which is approximately 3.4898%. VANGUARD GROUP INC, holding 0.19 million shares of the stock with an approximate value of $$45959.0 in TOVX stocks shares; and VANGUARD GROUP INC, currently with $$44703.0 in TOVX stock with ownership which is approximately 1.1033%.
